Language
Language
Helios Logo

A New Study is Enrolling Pregnant and Nonpregnant Women

Join a Maternal RSV Research Study

A clinical study is evaluating RSV vaccine use during pregnancy to understand effects on infant protection. You may be eligible if you’re pregnant or previously received an RSV vaccine during pregnancy.

Required
Required
Required
Required
Please enter 10 digits for phone number. Required when opting in to SMS.
You must consent to the privacy policy.
If you consent to SMS messages, you must provide a phone number.

Purpose of the Study

The purpose of this study is to better understand how maternal RSV immunization may impact infant outcomes.

Study Requirements

• You may qualify if you are:

    o A woman between 18 and 49 years old
    o Currently pregnant, or previously received an RSV vaccine as part of a clinical trial

Potential Benefits of Participation

Icon 1

Access to new treatments that are not yet available to the general public.

Icon 2

Personalized medical attention from leading healthcare professionals.

Icon 3

Compensation provided to qualified participants

Study Locations

This study is currently enrolling at the following sites:

    Helios Clinical Research - Weatherford

About Helios Clinical

Helios Clinical is dedicated to advancing medical research through innovative clinical trials.
Our mission is to discover new ways to improve patient health and outcomes.
We collaborate with leading healthcare professionals and scientists
to ensure the highest standards of research and care for our participants.

Privacy Policy Current Studies Helios Highlights
We Know Time is Precious

© 2024 Helios Clinical. All rights reserved.